
Sheldon Holder
Physician · University of Michigan Health-West
Credentials: · · · · ·
History
2026–Present
- 2010–2013
Vanderbilt Ingram Comprehensive Cancer Center

Research
Systematic review or meta-analysis · The Oncologist · 2016 · 391 citations
The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death
Journal of Biological Chemistry · 2003 · 236 citations
Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase
Molecular Cancer Therapeutics · 2007 · First of 7 authors · 148 citations

16 papers

16 papers

6 papers

6 papers · 2 as a fellow

5 papers

5 papers

3 papers

3 papers
Clinical trials
- 2023–2025
Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant
Principal investigator · Terminated · Phase 1
Brown University
- 2019–2022
A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
Principal investigator · Terminated · Phase 1
Brown University

